AstraZeneca Pays $520 Million to Settle Seroquel Whistleblower Claims

AstraZeneca has agreed to pay $520 million in civil fines, penalties and damages to settle allegations that the company defrauded Medicare, Medicaid and other government-funded programs in connection with its marketing and promotional practices for the blockbuster atypical antipsychotic Seroquel.

Read the Press Release Here!